I VACCIN Hospitalization of COVID-19 Patients
NCT05244343 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1096
Last updated 2022-04-01
Summary
A REALLIFE evaluation of rate of hospitalized patients in Intensive Care Units and in medical Units of non -vaccinated patients vs vaccinated patients
Conditions
- SARS CoV 2 Infection
- COVID-19
Sponsors & Collaborators
-
Eshmoun Clinical Research Center
lead NETWORK
Principal Investigators
-
Mariem Melliti · Eshmoun Clinical Research Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-25
- Primary Completion
- 2022-03-03
- Completion
- 2022-03-10
Countries
- Tunisia
Study Locations
More Related Trials
-
Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19
NCT04350931 ·Status: UNKNOWN ·Phase: PHASE3
-
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
NCT04659941 ·Status: UNKNOWN ·Phase: PHASE2
-
Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study
NCT04384614 ·Status: WITHDRAWN
-
Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19
NCT04551755 ·Status: UNKNOWN ·Phase: PHASE2
-
Risks of Bacterial and Fungal Superinfection in Patients With COVID-19
NCT05256316 ·Status: COMPLETED
-
Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers
NCT04461379 ·Status: UNKNOWN ·Phase: PHASE3
-
SARS-CoV-2 Infection in COVID-19 Vaccinated Patients
NCT05060939 ·Status: COMPLETED ·Phase: NA
-
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
NCT04832932 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Study in the Treatment of Patients With Moderate Course of COVID-19
NCT04842435 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Case Fatalities in Hospitalised COVID-19 Patients in the UK
NCT04527458 ·Status: COMPLETED
-
Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection
NCT04523831 ·Status: COMPLETED ·Phase: PHASE3
-
SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study
NCT04832945 ·Status: COMPLETED
-
SARS-CoV-2 Infection Among Healthcare Workers
NCT05680896 ·Status: UNKNOWN
-
Microbial Infection and AMR in Hospitalized Patients With Covid 19
NCT04479982 ·Status: UNKNOWN
-
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
NCT05020145 ·Status: COMPLETED
-
Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill
NCT04358809 ·Status: UNKNOWN ·Phase: PHASE3
-
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
NCT04328441 ·Status: COMPLETED ·Phase: PHASE3
-
Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition.
NCT06057025 ·Status: UNKNOWN ·Phase: PHASE3
-
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.
NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3
-
SARS-CoV-2/COVID-19 Infection Among Health Care Workers
NCT04826718 ·Status: COMPLETED
-
COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2
NCT04318314 ·Status: UNKNOWN
-
Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai
NCT05422963 ·Status: UNKNOWN
-
Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19
NCT04353518 ·Status: UNKNOWN ·Phase: PHASE3
-
The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers
NCT05942820 ·Status: TERMINATED ·Phase: PHASE1
-
Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers
NCT00778388 ·Status: COMPLETED ·Phase: PHASE1